SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-048138
Filing Date
2020-10-28
Accepted
2020-10-28 06:02:06
Documents
10
Period of Report
2020-10-28

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20201028.htm 6-K 19306
2 EX-99.1 tlc-ex991_6.htm EX-99.1 256745
3 GRAPHIC gr5r1audsiu1000005.jpg GRAPHIC 2049
4 GRAPHIC gr5r1audsiu1000004.jpg GRAPHIC 4538
5 GRAPHIC gr5r1audsiu1000003.jpg GRAPHIC 2049
6 GRAPHIC gr5r1audsiu1000001.jpg GRAPHIC 2049
7 GRAPHIC gr5r1audsiu1000008.jpg GRAPHIC 4538
8 GRAPHIC gr5r1audsiu1000006.jpg GRAPHIC 4538
9 GRAPHIC gr5r1audsiu1000007.jpg GRAPHIC 2049
10 GRAPHIC gr5r1audsiu1000002.jpg GRAPHIC 4538
  Complete submission text file 0001564590-20-048138.txt   314607
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 201265984
SIC: 2834 Pharmaceutical Preparations